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Abstract
Introduction: Aggressive, recurrent embolisms require accurate etiologic diagnosis. We describe the case of a 69-
year-old Italian Caucasian woman with recurrent arterial embolisms in whom several sources and triggers of
thrombosis were detected.
Case presentation: The patient, a 69-year-old Italian Caucasian woman, presented with a systemic embolism that
was initially attributed to atrial fibrillation. The recurrence of embolisms despite anti-thrombotic therapy prompted
a re-evaluation of the clinical presentation. New potential causes of thrombosis emerged in this patient, including
thrombocytosis associated with the JAK2 V617F mutation and the very rare mural thrombosis of the descending
aorta. A mural thrombus in the pulmonary artery was detected contiguous with the aortic mural thrombosis,
raising the possibility of a clinically silent ductus Botalli as the initiating event. The patient was treated with
warfarin, aspirin, hydroxyurea, and surgery.
Conclusions: The diagnosis was achieved via systematic use of imaging procedures and reconsideration of blood
tests performed to explore the diagnosis of thrombosis. This allowed a deeper and more detailed analysis of the
case beyond the conventional approach, which would have aimed to identify one cause for the condition at hand,
in this case, atrial fibrillation. The broader approach that we used resulted in the diagnosis of multiple embolisms
from multiple sites and multiple causes.
Introduction
The etiologic diagnosis of arterial embolisms is challen-
ging. Embolisms may arise from cardiac thrombi, patent
foramen ovale, atrial septal aneurysms associated with
paradoxical embolisms, and complicated atherosclerotic
lesions of the aortic arch. The recurrence of embolisms
while the patient is undergoing an anti-thrombotic regi-
men may underline multiple causes of thrombosis,
including exceptional cases of mobile thrombi in the
aortic arch in the absence of diffuse atherosclerosis that
have been reported recently [1]. Transesophageal echo-
cardiography is of valuable help for the detection of
mobile thrombi with high embolic potential. We
describe the case of a 69-year-old Italian Caucasian
patient with recurrent arterial embolisms in whom sev-
eral sources and triggers of thrombosis were detected.
Case presentation
A 69-year-old Italian Caucasian woman arrived at the
emergency department presenting with sudden onset of
lower left limb pain. The patient reported no dyspnea,
chest pain, weight loss, nausea, abdominal pain, hema-
turia, myalgias, or arthralgias. Her medical history was
notable for type 2 diabetes mellitus and chronic atrial
fibrillation. She had no history of coronary heart disease,
hypertension, or dyslipidemia, and she did not smoke.
Her medications included digoxin and repaglinide, but
not anti-thrombotic drugs.
The patient’s physical examination revealed that she
appeared to be in good condition, but she reported dis-
comfort due to pain in the left leg. The patient’s blood
pressure was 125/85 mmHg, and her heart rate was 80
beats/minute and irregularly irregular. Her respiratory
rate was 22 breaths/minute, her oxygen saturation was
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her body temperature was 36°C.
In her left leg, femoral, popliteal, and tibial pulses
were absent, with pale and cool feet and with slow capil-
lary return. Her right leg was absent of tibial pulse. Her
Ankle Brachial Pressure Index was 0 on the left and 0.4
on the right. The motor and sensory functions of the
legs were preserved.
A transesophageal echocardiogram revealed enlarge-
ment of the left atrium with a thrombus in its appen-
dange and enlargement of the right atrium. She had no
signs of atrial shunt or detectable atherosclerosis in the
proximal aorta. A diagnosis of embolizing non-valvular
atrial fibrillation was confirmed, and the patient under-
went lower left limb Fogarty thromboembolectomy, that
successfully restored distal blood flow. The patient was
discharged after two days to a low molecular weight
heparin regimen as bridging therapy for a warfarin
regimen.
After one week, the patient returned to the emergency
department with acute ischemic symptoms in her left
leg. Angiography was performed, which showed an
apparently normal wall of the abdominal aorta, right
iliac and femoral artery branches, obstruction of the left
external iliac artery and total obstruction of the left
femoral artery branches, and obstruction of the right
popliteal artery and of the tibial-peroneal axes on both
sides. Urgent embolectomy was again performed with
subsequent restoration of blood flow, and the patient
was discharged under warfarin therapy.
After four weeks, the patient returned with left leg
pain at rest. A search for a hypercoagulable state
revealed normal thrombin, pro-thrombin, and partial
thromboplastin times; normal anti-thrombin III, protein
S, and protein C antigens; and a normal protein C path-
way, activated protein C resistance, and homocysteine
level. Screening for anti-cardiolipin antibodies and lupus
anti-coagulant were negative, and her anti-nuclear anti-
body test was negative. Her erythrocyte sedimentation
rate was 8 mm/hour. Her blood cell count revealed nor-
mal amounts of red and white cells, and her platelet
count was 850,000/μl.
Transesophageal echocardiography showed resolution
of the atrial thrombus; however, an intra-luminal pyra-
midal lesion (1.4 cm×1.5 cm in size) with an irregular
surface was seen on the anterior wall of the descending
aorta (Figure 1). Computed tomography (Figure 2) with
contrast medium confirmed the presence of a mural
aortic thrombus in the anterior wall of the descending
aorta extending 1.5 cm distally, a mural thrombus in the
left pulmonary artery localized in close proximity to the
aortic thrombus, a lung infarction in the inferior left
l o b e ,a ni n f a r c t i o ni nt h es p l een, sparse atherosclerotic
plaques in the abdominal aorta and the right femoral
artery, occlusion of the left external iliac artery, and
occlusion of the right internal iliac artery. There were
no signs of venous thrombosis.
The patient underwent surgical treatment consisting
of an endovascular exclusion of thrombus with a Zenith
32 mm×80 mm endoprosthesis (Cook, Inc., Blooming-
ton, IN) implanted just after the emergence of the left
anonym subclavian artery, a subsequent thromboembo-
lectomy of the left external iliac artery, and a femoro-
popliteal bypass. The patient was discharged after a few
days under a low molecular weight heparin regimen as
bridging therapy for a warfarin regimen, as well as
aspirin. Additional therapy included b-blockers and
hydroxyurea, an anti-neoplastic drug acting on nucleic
Figure 1 A trans-esophageal echocardiographic scan showing
an intra-luminal pyramidal lesion 1.4 cm×1.5 cm in size with
an irregular surface on the anterior wall of the descending
aorta (arrow).
Figure 2 A computed tomography slice of the thorax showing
a mural aortic thrombus in the anterior wall of the descending
aorta and a mural thrombus in the left pulmonary artery
localized in close proximity to the aortic thrombus.
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count decreased to 300,000/μl.
Two months later an echocardiographic Doppler study
revealed the patency of the bypass and the left femoral
axis, which previously had been treated by embolect-
omy. Two months later the patient presented with left
leg pain while she was being treated with warfarin. An
echocardiographic Doppler scan showed obstruction of
the popliteal bypass. Therapy with aspirin, clopidogrel,
and warfarin was initiated. Out-patient follow-up was
arranged, and eight months later the patient did not
report any further embolization.
Discussion
Our patient presented with recurrent overt episodes of
peripheral embolization and subclinical pulmonary and
spleen embolism. The first reported episode of periph-
eral embolism in our patient was associated with left
atrial appendange thrombosis as a consequence of atrial
fibrillation that was not anti-thrombotic prophylaxis.
Atrial fibrillation is the most prevalent cardiac dysrhyth-
mia and is a strong independent risk factor for both sys-
temic embolism and stroke [2]. Systemic embolic events
associated with atrial fibrillation are cerebral in 85% of
cases and peripheral in 15% [3]. According to the cur-
rent guidelines [4], the patient presented here should
have been treated with aspirin or warfarin.
In our patient, the subsequent embolization occurred
after we initiated anti-coagulation therapy. This therapy
was associated with the resolution of atrial thrombosis
and the appearance of a mural thrombus localized in
the descending aorta as a consequence of the underlying
thrombocytosis and, eventually, some degree of athero-
sclerosis. Peripheral embolization is of cardiac origin or
due to atherosclerosis of the abdominal aorta in 85% of
cases [5]. Peripheral embolisms associated with athero-
sclerosis of the abdominal aorta generally occur in the
presence of advanced and complicated lesions. The
angiogram in our case, however, did not show appreci-
able atherosclerosis of the abdominal aorta.
The initiation of anti-coagulation therapy is not suffi-
cient to fully prevent further episodes of embolization
from the atrial thrombus. Patients with atrial fibrillation
and dense spontaneous echocontrast have a high likeli-
hood of cerebral embolism (22%) or death, despite the
use of oral anti-coagulation therapy [6]. In the first days
after initiation of anti-coagulation treatment, the risk of
embolization remains high. A transient pro-thrombotic
state can be induced by excessive doses of warfarin,
which rapidly depletes circulating protein C [7]. On the
other hand, embolectomy is associated with a recurrence
rate of thrombosis of 4% to 7% [8].
Recurrent thromboembolism under warfarin treatment
should prompt the clinician to search for other factors,
including a hypercoagulable state or vasculitis. In addi-
tion, trans-esophageal echocardiography should be
repeated to assess the state of the previously recognized
atrial thrombosis. The only relevant alteration, in the
blood analysis results in our patient, was the marked
increase in the number of platelets, which was not pre-
sent at the first admission.Thrombocytosis is per se
complicated by major thrombosis, with a rate as high as
approximately 50% [9]. Two possible explanations could
account for our patient’s normal platelet count at
admission: either this was a reactive thrombocytosis or
thrombocytosis was misdiagnosed at admission for the
eventual occurrence of artefactual platelet count [10]. In
the event of preexisting thrombocytosis, we tested the
patient for positivity for the JAK2 V617F mutation to
establish whether it was essential thrombocytosis
according to the recently revised diagnostic criteria [11].
Essential thrombocytosis, which is one of the conditions
of myelo-proliferative disorders, is associated with JAK2
mutation in up to 40% to 50% of cases. Actually, a poly-
merase chain reaction assay confirmed the presence of
the JAK2 V617F mutation. JAK2 is a member of the
Janus kinase family that is implicated in cellular signal-
ing in connection with several receptors. The change of
valine to phenylalanine at the 617 position is a gain of
function mutation that renders hematopoietic cells more
sensitive to growth factors such as thrombopoietin.
The imaging results in the present case revealed the
disappearance of atrial thrombosis and the appearance
of new thrombi attached to the wall of the descending
aorta and in the pulmonary artery. The thrombus in the
descending aorta, also known as the mural thrombus, is
a very rare cause of systemic embolization. A mural
thrombus in the pulmonary artery has never been
reported. The atrial thrombus and the mural thrombi in
the descending aorta and in the pulmonary artery can
be associated with limb, spleen, and lung embolization.
Fortunately, the patient’s brain circulation was saved
from embolic events, as the aortic mural thrombi grew
after the emergence of the left subclavian artery. Even-
tually, the atrial emboli were too large in diameter to
enter the carotid branch and traveled downstream.
Thrombocytosis and the eventual alteration of the arter-
i a lw a l lf a v o r e dt h ed i a g n o s is of aggressive thromboem-
bolism in this patient.
Thrombosis of the aortic arch is an infrequent cause
of systemic embolisms. Machleder et al. [12] reported
10,671 consecutive autopsies in which aortic mural
thrombus was identified in 48 of the cases (a 0.45% inci-
dence) in aortas of normal caliber and configuration.
Thirty-eight patients had mural thrombi confined to the
abdominal aorta, one had a mural thrombus in the thor-
acic aorta, and nine had mural thrombi in both the
thoracic and the abdominal aorta [12]. In 1997,
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ranging in age from 26 to 61 years with unexplained
arterial embolisms with mobi l ea o r t i ca r c ht h r o m b o s e s
detected by trans-esophageal echocardiography. Of the
27,855 examinations, 23 cases were detected (a 0.08%
incidence) [1]. In their study, a large proportion of cases
was associated with a certain degree of atherosclerosis,
but one patient did not have measurable atherosclerosis,
and 90% of cases were associated with atherosclerosis
risk factors. In this series of cases, intravenous unfractio-
nated heparin was used to manage embolic events; how-
ever, in 17% of the cases, embolisms recurred despite
heparin administration. Forty-three percent of the
patients had multiple embolisms affecting more than
one territory.
Several authors have reported the association of aortic
mural thrombi with hypercoagulable states, including
resistance to protein C and hyperhomocysteinemia [13].
However, it is likely that most, if not all, aortic mural
thrombi occur because of an endothelial perturbation
triggered by some grade of atherosclerosis or inflamma-
tion, albeit undetectable using current imaging
procedures.
Accordingly, most patients diagnosed with aortic
mural thrombi are positive for atherosclerosis risk fac-
tors, including our patient, who has type 2 diabetes mel-
litus. Taken together, these elements satisfactorily
explain the occurrence of aortic mural thrombus in our
patient. In this case, however, the occurrence of aortic
mural thrombus along with contiguous pulmonary
artery thrombosis is novel and has never been reported
in the literature. Thrombosis in the pulmonary arteries
was not caused by venous thromboembolism, which was
excluded by computed tomographic angiography. We
have presented the case of a patient with a mural
thrombus in the pulmonary artery, which was likely trig-
gered by alteration of the endothelial lining in a manner
similar to the mural thrombus of the aorta. Athero-
sclerosis can be excluded as the underlying disease, as
pulmonary arteries are not typically affected by this dis-
ease. The question, then, is why our patient developed
mural thrombosis of the pulmonary artery. The spatial
and temporal contiguity of the two mural thromboses,
in the aorta and the pulmonary artery, may help in
addressing this question.
The computed tomographic image in Figure 1 shows
that the aortic and pulmonary artery walls involved in
mural thrombosis are in close contiguity with one
another. In addition, it is likely on the basis of the clini-
cal evolution that the two thromboses developed almost
simultaneously. Two possible causes that may act trans-
arterially are inflammatory or infectious processes. This
hypothesis, however, may not be accurate, as we did not
find any marker of inflammation or infection in the
blood, such as increases in white blood cell count, C-
reactive protein, anti-nuclear antibody titers, erythrocyte
sedimentation rate, or body temperature.
One possible explanation involve the mechanical stress
at the point of contact between the two vessels, with a
point of tension during the systolic wave, which even-
tually increases from the potential arterial stiffness in a
patient with multiple risk factors for atherosclerosis.
Mechanical stress of the wall could affect the endothelial
homeostasis, with a shift toward thrombogenesis.
It should be emphasized that thrombosis occurred at
an interface of the two vessels in the area of the ances-
tral communication between the systemic and pulmon-
ary circulation: the ductus Botalli. Although its
distribution and size may vary, the ductus Botalli nor-
mally extends antero-superiorly from the anterior mar-
gin of the descending aorta to the superior margin of
the pulmonary artery adjacent to the orifice of the left
pulmonary artery, and obliquely from right to left [14].
Patent ductus Botalli (PDB) in young patients, an iso-
lated anomaly and the most common lesion in the field
of congenital cardiac diseases, is readily recognized and
can be surgically corrected with minimal risk. Occasion-
ally, the ductus Botalli escapes detection, and the patient
survives to adulthood. In a series of cases of PDB in
patients over 50 years old at the Mayo Clinic from 1945
to 1983, two-thirds of the patients with PDB were
women [15]. Some cases of PDB have been reported in
adults over 80 years of age, including a case of a 91-
year-old woman in Japan who survived without ductus
closure [16].
A small PDB causes no symptoms, and a person with
a small defect has a normal life expectancy [17]. How-
ever, small PDB is associated with an elevated risk of
infectious endocarditis, and thromboembolic events are
the most serious reported complications [18].
A communication, even small and not affecting hemo-
dynamics, could reconcile the diagnosis. In fact, the per-
sistence of this communication could eventually perturb
shear stress and favor a diagnosis of thrombosis. PDB is
also associated with local atherosclerosis and calcifica-
tion [19].
Conclusions
Many cases similar to the one presented here are
encountered during common clinical practice, in which
the diagnosis cannot definitively be proven but is the
most likely possibility. In the present case, the diagnosis
was achieved via systematic use of imaging procedures
and reconsideration of blood tests that explored throm-
bosis. This allowed a deeper and more detailed analysis
of the case beyond the conventional approach that
would have aimed to identify one cause for the condi-
tion at hand, in this case, atrial fibrillation. This broader
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lisms from multiple sites and as a result of multiple
causes.
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